These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37626694)

  • 1. Computational,
    Boyuklieva R; Zagorchev P; Pilicheva B
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose-to-brain drug delivery.
    Haasbroek-Pheiffer A; Van Niekerk S; Van der Kooy F; Cloete T; Steenekamp J; Hamman J
    Biopharm Drug Dispos; 2023 Feb; 44(1):94-112. PubMed ID: 36736328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress on traditional Chinese medicine in preventing and treating cerebral ischemia injury based on "nose-brain" pathway].
    Wei ZZ; Fang XY; Fan SK; Peng MF; Bai M; Miao MS
    Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4800-4805. PubMed ID: 31872585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood-brain barrier and nasal drug delivery to the central nervous system.
    Miyake MM; Bleier BS
    Am J Rhinol Allergy; 2015; 29(2):124-7. PubMed ID: 25785753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease.
    Arora D; Bhatt S; Kumar M; Vattikonda HDC; Taneja Y; Jain V; Joshi V; Gali CC
    Curr Pharm Des; 2020; 26(27):3281-3299. PubMed ID: 32228421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nose-to-Brain Delivery.
    Wang Z; Xiong G; Tsang WC; Schätzlein AG; Uchegbu IF
    J Pharmacol Exp Ther; 2019 Sep; 370(3):593-601. PubMed ID: 31126978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal delivery of neurotherapeutics
    Rajput A; Pingale P; Dhapte-Pawar V
    Front Pharmacol; 2022; 13():979682. PubMed ID: 36176429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.
    Cunha S; Amaral MH; Lobo JMS; Silva AC
    Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling.
    Wang Q; Zhang Y; Wong CH; Edwin Chan HY; Zuo Z
    AAPS J; 2017 Dec; 20(1):23. PubMed ID: 29282567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intranasal delivery route of drug administration for brain targeting.
    Erdő F; Bors LA; Farkas D; Bajza Á; Gizurarson S
    Brain Res Bull; 2018 Oct; 143():155-170. PubMed ID: 30449731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery systems from nose to brain.
    Misra A; Kher G
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation.
    Tiozzo Fasiolo L; Manniello MD; Banella S; Napoli L; Bortolotti F; Quarta E; Colombo P; Balafas E; Kostomitsopoulos N; Rekkas DM; Valsami G; Papakyriakopoulou P; Colombo G; Russo P
    Int J Pharm; 2021 Aug; 605():120827. PubMed ID: 34171428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of cell-penetrating peptides and penetration accelerating sequence for nose-to-brain delivery of glucagon-like peptide-2.
    Akita T; Kimura R; Akaguma S; Nagai M; Nakao Y; Tsugane M; Suzuki H; Oka JI; Yamashita C
    J Control Release; 2021 Jul; 335():575-583. PubMed ID: 34116136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats.
    Hoekman JD; Ho RJ
    Anesth Analg; 2011 Sep; 113(3):641-51. PubMed ID: 21709146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.